CAMBRIDGE, Mass., May 22, 2024 /PRNewswire/ — GV20 Therapeutics, a clinical-stage biotechnology company integrating AI, genomics, and disease biology to create next-generation antibody therapeutics for cancer, announced today that it will present at the Jefferies Global Healthcare…